Senzime AB (publ) (STO:SEZI)
Sweden · Delayed Price · Currency is SEK 5.94
-0.22 (-3.57%)
Oct 31, 2025, 12:59 PM CET
Senzime AB Revenue
Senzime AB had revenue of 26.48M SEK in the quarter ending September 30, 2025, with 52.12% growth. This brings the company's revenue in the last twelve months to 89.71M, up 62.24% year-over-year. In the year 2024, Senzime AB had annual revenue of 58.48M with 63.55% growth.
Revenue (ttm)
89.71M
Revenue Growth
+62.24%
P/S Ratio
10.41
Revenue / Employee
1.66M
Employees
54
Market Cap
933.86M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 58.48M | 22.72M | 63.55% |
| Dec 31, 2023 | 35.75M | 21.72M | 154.77% |
| Dec 31, 2022 | 14.03M | 3.05M | 27.81% |
| Dec 31, 2021 | 10.98M | 1.64M | 17.60% |
| Dec 31, 2020 | 9.34M | 2.63M | 39.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 35.85B |
| Swedish Orphan Biovitrum AB | 27.85B |
| Medicover AB | 25.22B |
| Elekta AB | 17.84B |
| Asker Healthcare Group AB | 15.88B |
| AddLife AB | 10.53B |
| Nolato AB | 9.57B |
| Vitrolife AB | 3.51B |
Senzime AB News
- 3 days ago - Senzime AB (publ) 2025 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 3 days ago - Senzime AB (publ) (SNZZF) Q3 2025 Earnings Call Prepared Remarks Transcript - Seeking Alpha
- 4 days ago - Senzime Q3 2025: Strong Growth and Clear Steps Towards Profitability - Accesswire
- 9 days ago - Invitation to Presentations of Senzime's Third Quarter 2025 Report - Accesswire
- 24 days ago - Senzime Launches EMGINE, The Next-Generation Software Suite Advancing Neuromuscular Monitoring - Accesswire
- 4 weeks ago - Senzime Welcomes New European Pediatric Guidelines Recommending EMG-Based Neuromuscular Monitoring - Accesswire
- 5 weeks ago - Senzime AB (publ) (SNZZF) Senzime AB (publ) Presents at Pareto Securities' 16th Annual Healthcare Conference 2025 - Slideshow - Seeking Alpha
- 6 weeks ago - Senzime Awarded Contract to Supply the U.S. Department of Defense and Walter Reed National Military Medical Center - Accesswire